Recombinant

Using Bacteriophage Enzymes to Stay One Step Ahead of MRSA

By: Davidta Brown, Copy Editor [Content-Focused] - It’s difficult to have a discussion about antibiotics without mentioning the developing crisis…

12 years ago

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

Ebola Outbreak in West Africa

By: Azia Tariq, Staff Editor - The first recorded outbreak of the Ebola Zaire (ZEBOV), a strain of the ebola…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

After 15 Years, First New Recombinant Coagulation Factor IX (Rixubis) Gains Orphan Drug Approval

By: Tamara Yunusova, Senior Staff Editor - After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor…

13 years ago

Xigris: A Worldwide Withdrawal

By: Khilna Patel, Pharm.D. Candidate c/o 2012 - On October 25 of this year, Eli Lilly and Company announced a…

14 years ago